Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DPPA3 pseudogene 11 is a non-protein coding gene classified as a processed pseudogene of the DPPA3 (Developmental Pluripotency Associated 3) gene[1]. Like other pseudogenes, DPPA3P11 is a genomic remnant resembling its functional parent but has lost protein-coding ability due to mutations, truncations, or lack of proper regulatory sequences[3]. Pseudogenes can play regulatory roles at the RNA level, such as acting as competitive endogenous RNAs, producing small interfering RNAs, or serving as microRNA decoys[3]. However, there is currently no evidence that DPPA3P11 itself acts as a functional regulator or therapeutic target. Its inclusion as a target would be incorrect according to structural and therapeutic conventions: therapeutic targets are typically proteins or functional RNAs with well-defined pharmacological roles. DPPA3P11 lacks these critical features and is not targeted by drugs nor used as a clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DPPA3 pseudogene 11 (DPPA3P11).